CoChat
Sign Up
Cited by 117Growth Hormone and Insulin-like Growth FactorsPituitary Gland Disorders and TreatmentsHypothalamic control of reproductive hormones

The DOI matches its Crossref record; 43 of the 51 references it cites were found in a registry or an index.

Body Mass Index Determines Evoked Growth Hormone (GH) Responsiveness in Normal Healthy Male Subjects: Diagnostic Caveat for Adult GH Deficiency

Bonert, Vivien S., Elashoff, Janet D., Barnett, Philip, Melmed, Shlomo·2004·The Journal of Clinical Endocrinology & Metabolism
DOI 10.1210/jc.2003-032213
Open this paper in CoChat — free account

Abstract

GH secretion is decreased in obese subjects, whereas age-adjusted IGF-I concentrations are normal. This study was undertaken to rigorously delineate the extent of obesity [elevated body mass index (BMI)] associated with decreased somatotrope secretory function resulting in apparent adult GH deficiency. The peak GH response evoked by combined arginine (0.5 g/kg infused iv over 30 min) and GHRH (1 μg/kg iv bolus) was measured in 59 healthy male subjects with BMIs ranging from normal to obese. BMI correlated with the peak evoked GH response (Pearson r = −0.59; P < 0.01), and the percentage of subjects exhibiting an abnormal evoked GH response, i.e. less than 9 ng/ml, increased from 5% for those with a BMI less than 25 (normal), to 13% for those with a BMI of 25–26.9 (mildly overweight), to 33% for those with a BMI of 27–29.9 (moderately overweight), and to 64% for those with a BMI of 30 or more (obese). BMI is a major determinant of evoked adult GH response to provocative testing. The diagnosis of adult GH deficiency using the evoked GH response in patients with even mild BMI elevation does not accurately distinguish normal from deficient responses and may result in the erroneous classification of obese subjects as GH deficient and thus unnecessarily requiring GH replacement.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2003-032213

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 51 references

Research works printed but not linked: 3

  1. 1998, Consensus guidelines for diagnosis and treatment of adults with GH deficiency. Port Stephens workshop., J Clin Endocrinol Metab, 83, 379
  2. Williamson, 1997, International weight loss: patterns in the general populations and its association with morbidity and mortality, Int J Obes Relat Metab Disord, 21, S14
  3. Veldhuis, 1991, Dual effects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in men., J Clin Endocrinol Metab, 72, 51, 10.1210/jcem-72-1-51 · DOI

Cited by

Sorted by citations

Related

See all

Metadata

Authors
Bonert, V. S., Elashoff, J. D., Barnett, P., & Melmed, S.
Affiliations
Cedars-Sinai Medical Center (US)
Corresponding author
Melmed, Shlomo
ORCID
Melmed, Shlomo
Venue
The Journal of Clinical Endocrinology & Metabolism
Publisher
The Endocrine Society
Published
2004-07-01
Volume
89
Issue
7
Pages
3397-3401
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
DOI
10.1210/jc.2003-032213
OpenAlex
W2077882762
Semantic Scholar
04faa9590eb74151571ede7ccd843eecfcee62d9
Cited by
117
References
51
Citations by year
2026: 2 · 2025: 2 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 3 · 2020: 3 · 2019: 2 · 2018: 1 · 2017: 3 · 2016: 3 · 2015: 7 · 2014: 4 · 2013: 7 · 2012: 7
FWCI
7.85
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Eli Lilly and Company
  • National Cancer Institute (R01CA075979, CA-75979)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
Keywords
adult growth hormone deficiency, body mass index, obesity, arginine stimulation, GHRH stimulation, provocation tests, insulin-like growth factor I, growth hormone replacement therapy, diagnostic accuracy
MeSH terms
Adult, Aging, Arginine, Humans, Insulin-Like Growth Factor I, Male, Middle Aged, Obesity, Growth Hormone-Releasing Hormone, Time Factors, Body Mass Index, Case-Control Studies, Human Growth Hormone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review